Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy

NCT06356675 is registered in ClinicalTrials.gov with The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine as lead sponsor.

NCT NCT06356675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06356675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
Lead sponsor
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 1, 2024
Completion date
July 1, 2028
Enrollment
33 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced nsclc